Don’t miss the latest developments in business and finance.

Bal Pharma receives revision in credit ratings from ICRA

Image
Capital Market
Last Updated : Mar 15 2021 | 6:31 PM IST
Bal Pharma has received upgrade in credit ratings from ICRA as under -

Long term fund based facilities - ICRA BB reaffirmed; Outlook revised to Stable from Negative.

Short term fund non fund based facilities - ICRA A4 reaffirmed

Long term - term loan - ICRA BB; Outlook revised to Stable from Negative.

Powered by Capital Market - Live News

Also Read

First Published: Mar 15 2021 | 6:14 PM IST

Next Story